Rochal Industries is a privately owned research company focusing on the develoment of new polymeric materials for wound and burn care treatment. Rochel licenses its intellectual property to companies capable of commercializing the resulting products. Rochel’s innovations serve a defined humaniterian need with anticipated revenues of a minimum $50 million market for its licensor. The partners of Rochel have over 200 US patents/patent applications between them with over $1 billion in resulting commercial sale from the patented products. Rochel’s scientists are the inventors of the chemistry for 3M’s Cavilon No String Barrier File, 3M Nexcare Spray Liquid Bandage and Sergeant’s epi-heal quick healing liquid bandage. Among othwer applications, these products are usedto protect skin from maceration due to incontinence or physiological fluid leakage.